Centene Corp
CNC
View Detailed Chart
32.575USD
-0.685-2.06%
Market hours （ET）Quotes delayed by 15 min
16.00BMarket Cap
7.79P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-2.06%
5 Days
+12.41%
1 Month
+20.96%
6 Months
-44.02%
Year to Date
-46.23%
1 Year
-56.77%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-12Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
21
analysts
Hold
Current Rating
35.656
Target Price
+7.20%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 174.96.
Fairly Valued
The company’s latest PE is 8.04, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 499.70M shares, decreasing 2.86% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 58.15M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 1.34.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.
Ticker SymbolCNC
CompanyCentene Corp
CEOMs. Sarah M. London
Websitehttps://www.centene.com/
